Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Shareholders' Equity

v3.25.1
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Series 2 Convertible Preferred Shares
Preferred Shares
Common Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at the beginning at Dec. 31, 2023     $ 97,590,426 $ (371,184) $ (93,465,946) $ 3,753,296
Balance at the beginning (in shares) at Dec. 31, 2023 1,166,667 18,885,254        
Condensed Consolidated Statements of Changes in Shareholders' Equity            
Share-based compensation     63,584     63,584
Issuance of Common Shares from ATM Offering (in shares)   75,862        
Issuance of Common Shares from ATM Offering     190,274     190,274
Re-measurement of liability-classified CAD stock options as of March 31, 2024     (294,967)     (294,967)
Net Income (Loss)         (3,635,088) (3,635,088)
Balance at the end at Mar. 31, 2024     97,549,317 (371,184) (97,101,034) 77,099
Balance at the end (in shares) at Mar. 31, 2024 1,166,667 18,961,116        
Balance at the beginning at Dec. 31, 2024     107,546,433 (371,184) (90,687,073) 16,488,176
Balance at the beginning (in shares) at Dec. 31, 2024   32,689,190        
Condensed Consolidated Statements of Changes in Shareholders' Equity            
Share-based compensation     245,295     245,295
Re-measurement of liability-classified CAD stock options as of March 31, 2024     86,163     86,163
Net Income (Loss)         (7,347,903) (7,347,903)
Balance at the end at Mar. 31, 2025     $ 107,877,891 $ (371,184) $ (98,034,976) $ 9,471,731
Balance at the end (in shares) at Mar. 31, 2025   32,689,190